🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib combination study is being conducted to assess the safety and...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02442063
Treatments Being Tested
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endomet...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale Tumori
Start Date
2017-03-20
Trial ID
NCT04302714
Treatments Being Tested
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
The present clinical study aims to verify the effectiveness and safety of t...
Status
Completed
Location
IRCCS Don Carlo Gnocchi
Start Date
2021-12-01
Trial ID
NCT05130814
This study will evaluate Comprehensive Chronic Care (CCC), a healthcare tre...
Status
Completed
Location
UW Health
Start Date
2022-08-08
Trial ID
NCT05382221
Treatments Being Tested
Acute Stanford type A aortic dissection (TAAD) is a life-threatening clinic...
Status
Enrolling By Invitation
Location
Francesco Nappi
Start Date
2014-01-01
Trial ID
NCT05912634
Treatments Being Tested
Failure of RFA has been attributed to technical failure of coagulating the ...
Status
Completed
Location
Assiut University
Start Date
2022-03-01
Trial ID
NCT05137652
Study to determine the best dose of stereotactic body radiation therapy (SB...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2018-03-15
Trial ID
NCT03431948
Treatments Being Tested
This phase I, open-label, single-arm, non-randomized clinical trial uses a ...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2026-06-15
Trial ID
NCT07567235
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550